Holen Sie sich die Stockscreener-App
38.63
0.69%
-0.27
Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.96%
59.04
|
53.70 | 55.68 | 55.62 | 49.05 |
| Depreciation and Amortization |
29.61%
0.599
|
0.851 | 1.734 | 0.602 | 0.354 |
| Operating Income/Loss |
9.96%
-59.04
|
-53.70 | -55.68 | -55.62 | -49.05 |
| Nonoperating Income/Loss |
31.73%
11.52
|
8.747 | 7.065 | 7.943 | 7.614 |
| Income/Loss From Continuing Operations Before Tax |
5.72%
-47.52
|
-44.95 | -48.62 | -47.68 | -41.44 |
| Income Tax Expense/Benefit, Deferred |
301.50%
0.403
|
-0.20 | -0.156 | -0.224 | 0.288 |
| Income Tax Expense/Benefit |
300.98%
0.412
|
-0.205 | -0.157 | -0.22 | 0.29 |
| Income/Loss From Continuing Operations After Tax |
7.13%
-47.93
|
-44.74 | -48.46 | -47.46 | -41.73 |
|
Net Income/Loss
|
7.13%
-47.93
|
-44.74 | -48.46 | -47.46 | -41.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7,460%
77.59
|
1.0263 | 66.00 | 65.86 | 65.72 |
| Diluted Average Shares |
7,460%
77.59
|
1.0263 | 66.00 | 65.86 | 65.72 |
| Basic Earnings Per Share |
3.13%
-0.62
|
-0.64 | -0.73 | -0.72 | -0.63 |
| Diluted Earnings Per Share |
3.13%
-0.62
|
-0.64 | -0.73 | -0.72 | -0.63 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):